About Solentim
Solentim is a company based in Wimborne Minster (United Kingdom) founded in 2010 was acquired by Advanced Instruments in August 2021.. The company has 47 employees as of June 30, 2021. Solentim offers products and services including OsmoTECH XT, OsmoPRO MAX, Artel MVS, and GloCyte. Solentim operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Wimborne Minster, United Kingdom
- Employees 47 as on 30 Jun, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Advanced Instruments Ltd.
- Date of Incorporation 15 Jun, 2010
- Jurisdiction WIMBORNE, DORSET, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$895.3 K (USD), Grant
Jun 01, 2019
-
Investors
Advanced Instruments
& 1 more
-
Employee Count
47
as on Jun 30, 2021
-
Acquired by
Advanced Instruments
(Aug 05, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Solentim
Solentim offers a comprehensive portfolio of products and services, including OsmoTECH XT, OsmoPRO MAX, Artel MVS, and GloCyte. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Single-sample micro-osmometer for bioprocessing measurements
Automated osmometer for clinical sample analysis
Multichannel system for liquid handling accuracy
Automated counter for CSF cell analysis in diagnostics
Funding Insights of Solentim
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $895,303
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2019 | Amount | Grant - Solentim | Valuation |
investors |
|
| Mar, 2019 | Amount | Grant - Solentim | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Solentim
Solentim has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Advanced Instruments and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
Manufacturer of Laboratory equipment
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Solentim
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Solentim
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Solentim Comparisons
Competitors of Solentim
Solentim operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
Dental implants and regenerative dentistry products are developed.
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Solentim
Frequently Asked Questions about Solentim
When was Solentim founded?
Solentim was founded in 2010 and raised its 1st funding round 9 years after it was founded.
Where is Solentim located?
Solentim is headquartered in Wimborne Minster, United Kingdom. It is registered at Wimborne Minster, Dorset, United Kingdom.
How many employees does Solentim have?
As of Jun 30, 2021, the latest employee count at Solentim is 47.
What does Solentim do?
Solentim was founded in 2010 and is based in Wimborne Minster, United Kingdom. Operations focus on the biotechnology sector, where cell lines are developed for biotherapeutics, including monoclonal antibodies derived from single cells. These are applied in treatments for conditions such as cancer, autoimmune diseases, and cardiovascular disorders. Services support discovery and manufacturing processes in the biopharmaceutical industry.
Who are the top competitors of Solentim?
Solentim's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Solentim offer?
Solentim offers OsmoTECH XT, OsmoPRO MAX, Artel MVS, and GloCyte.
Who are Solentim's investors?
Solentim has 2 investors. Key investors include Advanced Instruments, and European Union.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.